Drug factory · FDA FEI 3007014398

Corden Pharma GmbH

Otto-Hahn-Strasse 1, Plankstadt, Germany

Germany: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 15, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2009: 3 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
BicalutamideMakes it Golden State Medical Supply, Inc. 51407-010
GemcitabineMakes it, tests it and packages it Janssen Biotech, Inc. 57894-225
ResmetiromMakes it Madrigal Pharmaceuticals, Inc. 82576-060, 82576-080, 82576-100

FDA inspection history

EndedResultProgramProblems noted
Oct 15, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 14, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 6, 2018No problems foundDrug Quality Assurance—
Oct 24, 2014No problems foundDrug Quality Assurance—
Nov 17, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.